Stand out for this role — generate a tailored resume and cover letter in about a minute.
Janux Therapeutics, Inc. in San Diego, CA, seeks Associate Director, Clinical Operations to lead planning, initiation, execution and close-out of Phase I oncology trials, ensuring protocol adherence, GCP compliance, and high-quality data.
You will oversee CROs and vendors, mentor staff, drive site selection and enrollment, manage study documents and budgets, and collaborate across Clinical Development, Data Management, Regulatory Affairs, and Medical Affairs. Travel up to 15% may be required.
The Associate Director, Clinical Operations will be responsible for managing operational aspects of assigned clinical trials, with a focus on early-phase oncology studies. This includes oversight of contract research organizations (CROs), vendors, and clinical sites across both U.S. and international regions. The role requires a deep understanding of clinical trial processes, regulatory compliance (GCP, FDA, ICH), and the ability to lead cross-functional teams to ensure high-quality, timely, and cost-effective trial execution. The ideal candidate will bring an in-depth understanding of managing early phase oncology trials at a sponsor biotech.
$175,000 - $200,000 a year
In addition to a competitive base salary ranging from $175,000 to $200,000, we offer stock options, restricted stock units, a stock purchase plan (ESPP) and a target bonus. Janux also provides a comprehensive benefits package for our employees and their families, which includes medical, dental, vision, and supplemental disability insurance. Relocation assistance may also be available.
Please note that the base salary range is a guideline, and individual total compensation will vary based on factors such as qualifications, skill level, competencies, internal equity, and work location.
Full-time
Janux Therapeutics, Inc. is an equal opportunity employer that is committed to providing a work environment free of harassment and discrimination based upon a protected category, as well as an environment free from retaliation for protected activity.